Emergency Medicine

HIV / AIDS

Medical News

Primary Care

Surgery

Home » Archive by Category

Articles in the copd Category

Comment On The Publishing Of National Strategy For COPD Which Contains A Chapter On Asthma, UK
Wednesday, 24 Feb, 2010 – 2:00 | No Comment

Asthma UK’s Chief Executive Neil Churchill said: ‘The launch of a national strategy for COPD, which contains a chapter on the care of adult asthma, represents an important stepping stone towards national standards for asthma in England. ‘Asthma UK is currently working with PCTs across England to identify ways to improve care and reduce emergency admissions as tragically in the UK over 200 people a day are rushed to hospital with life-threatening asthma attacks…

Pipe and Cigar Smoking Strongly Associated with Decreased Lung Function, COPD
Monday, 15 Feb, 2010 – 23:00 | No Comment

Pipe and cigar smoke may be more harmful than once thought. While some believe pipes and cigars are healthier than cigarettes, a major known cause of chronic obstructive pulmonary disease (COPD), a new study directly links pipe and cigar smoking to decreased lung function.

Bio-Matrix Scientific Group’s Majority Owned Subsidiary Entest BioMedical Initiates Studies To Support Stem Cell / Laser Regenerative Therapy For COPD
Thursday, 4 Feb, 2010 – 1:00 | No Comment

Bio-Matrix Scientific Group Inc. (OTCBB: BMSN) announced that its majority owned subsidiary, Entest BioMedical Inc. (OTCBB: ENTB) has initiated studies to support the Company’s stem cell / laser regenerative therapy for Chronic Obstructive Pulmonary Disease (COPD). According to a Company spokesperson, Entest has begun to research the effects of Low Energy Near Infrared Radiation on cultured cells as a step toward animal pre-clinical studies for the treatment of COPD. Studies will be an extension of current Entest intellectual property covering enhancement of stem cell growth and activity…

A Heavy Toll: Canadian Thoracic Society Report Reveals True Cost Of Lung Disease
Wednesday, 3 Feb, 2010 – 4:00 | No Comment

More people are being admitted to Canadian hospitals with chronic obstructive pulmonary disease (COPD) than any other major chronic illness, and Canada’s death rate after COPD flare-ups (what some doctors call “lung attacks”) is the same as the death rate after heart attacks, according to a new report released today by the Canadian Thoracic Society (CTS), the medical arm of the Canadian Lung Association. The CTS report, entitled The Human and Economic Burden of COPD: A Leading Cause of Hospital Admission in Canada, underscores the need for COPD prevention and early diagnosis…

New potential to treat COPD
Friday, 29 Jan, 2010 – 6:24 | No Comment
New potential to treat COPD

Chronic obstructive pulmonary disease (COPD) is defined by emphysema and/or chronic bronchitis. It destroys the normal architecture of the lung and inhibits the mechanical aspects of breathing, which prevents necessary gas exchange. Patients suffer from coughing fits, wheezing, and increased occurence rate of lung infections. These symptoms are linked to changes in the architecture of the lung.

Cycling to better health, one leg at a time
Monday, 25 Jan, 2010 – 8:00 | No Comment

Improving fitness in patients with chronic obstructive pulmonary disease (COPD) goes a long way in improving their physical and mental health. Now, a series of studies report several innovative ways to help improve the fitness in COPD patients. All it takes is a little extra oxygen, or cycling on a stationary bicycle, using just one leg at a time.

Moxifloxacin May Be Better For COPD Outpatients According To New Research Published In The International Journal Of COPD
Sunday, 24 Jan, 2010 – 0:00 | No Comment

Chronic obstructive pulmonary disease (COPD) affects a large number of subjects worldwide and is characterised by a progressively rising epidemiological, clinical and socio-economic impact. The objectives of treatment are to decrease the burden of the disease through relief of symptoms, improvement of exercise tolerance, and prevention and treatment of exacerbations…

Tiotropium Appears to Cut Deaths, Cardiovascular Event Rates (CME/CE)
Tuesday, 5 Jan, 2010 – 20:01 | No Comment

Patients taking tiotropium bromide (Spiriva) for chronic obstructive pulmonary disease (COPD) appear to be at decreased risk for death and cardiovascular events compared with placebo, researchers said.

Lung Function And Risk Of COPD May Be Controlled By Genetic Variant
Friday, 18 Dec, 2009 – 3:00 | No Comment

Researchers have discovered evidence that suggests a genetic variant may be associated with better preserved lung function among children with asthma and adults who smoke, according to a new study funded by the National Heart, Lung, and Blood Institute (NHLBI), which is part of the National Institutes of Health. The study also found an association between the genetic variant and a lowered risk of developing chronic obstructive pulmonary disease (COPD) in adults who smoke. COPD is a lung disease most common among smokers, which makes it difficult to breathe…

Study Unveils Potential Genetic Links To Lung Disease Risk
Monday, 14 Dec, 2009 – 4:00 | No Comment

A new study involving data from more than 20,000 individuals has uncovered several DNA sequences linked to impaired pulmonary function. The research, an analysis that combined the results of several smaller studies, provides insight into the mechanisms involved in reaching full lung capacity. The findings may ultimately lead to better understanding of lung function and diseases like asthma and chronic obstructive pulmonary disease (COPD), the fourth leading cause of death in the United States..